Showing results (881-890 of 1,152) with videos related to

Sort By:
Pageof 116
Annals of Hematology|September 27, 2024
Rosai-Dorfman-Destombes disease in adults: a single center experienceEmily Leung, Collin Pryma, Stephen Murphy, et al.
Oncogene|October 10, 2017
Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness propertiesC-H Wang, P-J Wang, Y-C Hsieh, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 28, 2012
Quantum rotation of ortho and para-water encapsulated in a fullerene cageCarlo Beduz, Marina Carravetta, Judy Y-C Chen, et al.
Critical Care Explorations|October 16, 2020
The Association of Inflammatory Cytokines in the Pulmonary Pathophysiology of Respiratory Failure in Critically Ill Patients With Coronavirus Disease 2019Sophie Stukas, Ryan L Hoiland, Jennifer Cooper, et al.
Leukemia|November 17, 2010
The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemiaW-C Chou, W-C Lei, B-S Ko, et al.
Blood Cancer Journal|August 1, 2015
TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolutionH-A Hou, W-C Chou, Y-Y Kuo, et al.
Blood Cancer Journal|January 21, 2014
Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndromeT-C Chen, H-A Hou, W-C Chou, et al.
Leukemia|August 10, 2013
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemiaH A Hou, C C Lin, W C Chou, et al.
Antimicrobial Agents and Chemotherapy|February 14, 2018
Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of <i>cyp51A</i> Mutations on Estimation of Epidemiological Cutoff ValuesA Espinel-Ingroff, J Turnidge, A Alastruey-Izquierdo, et al.
Blood Advances|February 24, 2022
Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccinationAgnes Y Y Lee, Muntadhar Al Moosawi, Erica A Peterson, et al.
Pageof 116